Medication info
True Empagliflozin/Metformin Sustained Release Tablet 10/1000 mg

True Empagliflozin/Metformin Sustained Release Tablet 10/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Yellow, egg-shaped sustained-release film-coated tablet
Packaging
Domestic use - 30 tablets/bottle
Approval status
Active

MFDS item code 202501339 · Approved 2025.05.29 · Insurance code 641908700

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For antidiabetic therapy, this medicine may be administered as 1 tablet once daily with a meal to patients receiving empagliflozin 10 mg and metformin hydrochloride (extended-release) 1000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily with the evening meal. ⦁ Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive the same doses of empagliflozin and metformin as previously taken. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. ⦁ When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). No dose adjustment of this medicine is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≥ 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≥ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], this medicine may be used by adjusting the dose of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. - Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to less than 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 ml/min/1.73m2, this medicine must be discontinued immediately. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control abnormalities
  • cardiovascular diseases
View approved original text

This medication is used to assist in controlling blood sugar levels for adults with type 2 diabetes who find it difficult to manage through diet and exercise alone. It is particularly suitable for adults with type 2 diabetes who also have cardiovascular disease. The combination of empagliflozin and metformin effectively lowers blood sugar and aids in diabetes management. Additionally, positive impacts on reducing the risk of cardiovascular disease can be expected. Proper usage and precautions should be followed under professional guidance, and better effects can be achieved in conjunction with healthy eating and regular exercise. Therefore, this medication is used for blood sugar control and improvement of cardiovascular health in patients with type 2 diabetes.

How to take

Adult dose

For antidiabetic therapy, this medicine may be administered as 1 tablet once daily with a meal to patients receiving empagliflozin 10 mg and metformin hydrochloride (extended-release) 1000 mg. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily with the evening meal. ⦁ Patients switching from combination therapy with empagliflozin and metformin to this medicine should receive the same doses of empagliflozin and metformin as previously taken. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. ⦁ When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions in Precautions for Use). No dose adjustment of this medicine is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≥ 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2]. In patients with moderate renal impairment [CKD stage 3A, creatinine clearance (CrCl) ≥ 45 mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 mL/min/1.73m2 and <60 mL/min/1.73m2], this medicine may be used by adjusting the dose of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. - Since the starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000 mg. If creatinine clearance (CrCl) decreases to less than 45 ml/min or estimated glomerular filtration rate (eGFR) decreases to less than 45 ml/min/1.73m2, this medicine must be discontinued immediately. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is a diabetes treatment that combines two components to help control blood sugar levels. There may be a rare side effect called severe lactic acidosis when taking this medication, so caution is necessary. Lactic acidosis is a condition caused by an excessive buildup of lactic acid in the body, which can be life-threatening in severe cases. Additionally, when taken with insulin or other diabetes medications, there is a risk of hypoglycemia, which is when blood sugar levels drop too low, so caution is warranted. This medication should not be administered to patients with moderate to severe renal impairment, acute kidney problems, severe infections, or unstable heart function. Before any tests or surgeries that involve the use of iodine contrast agents, this medication should be temporarily discontinued and can be restarted only after kidney function has returned to normal. This medication may increase the risk of genital and urinary infections; therefore, if infection symptoms arise, prompt consultation with a doctor is necessary. Additionally, patients at risk of fluid loss, such as those experiencing dehydration, diarrhea, or vomiting, should use caution, and may temporarily stop taking the medication if necessary. During the course of this medication, vitamin B12 levels may decrease, so regular monitoring of vitamin B12 levels is recommended during prolonged use. It is safest for pregnant or possibly pregnant women and nursing mothers not to use this medication. This medication is not recommended for children under 18 years of age and should be used cautiously in elderly patients over 75 after thoroughly assessing kidney function. Overdosage may lead to severe side effects such as lactic acidosis, so the recommended dosages must be strictly adhered to, and immediate medical attention should be sought if an overdose is suspected. This medication should be swallowed whole without breaking or chewing, and the tablet shell may be excreted in the stool, which is a normal occurrence. Lastly, it is advisable to avoid alcohol consumption while taking this medication, and if symptoms of hypotension or dehydration appear, consult with a doctor for appropriate actions.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • decreased vitamin B12 and deficiency
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
Show 145 more
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
  • abnormal liver function tests
  • hepatitis
  • dysgeusia
  • pruritus
  • rash
  • urticaria
  • erythema
  • angioedema
  • dysuria
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • hypoglycemic episodes
  • decreased appetite
  • somnolence
  • hyperlipidemia
  • dyslipidemia
  • dizziness
  • headache
  • insomnia
  • vulvar pruritus
  • genital pruritus
  • fever
  • chest discomfort
  • chest pain
  • asthenia
  • weight loss
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • ischemic colitis
  • rectal bleeding
  • soft tissue infection
  • pneumonia
  • injury
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • cerebral infarction
  • headache
  • sensory impairment
  • orthostatic dizziness
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • urinary stones
  • acute kidney injury
  • chronic kidney disease
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • cervicitis
  • hyperglycemia
  • hyponatremia
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosis
  • eye discomfort
  • conjunctival congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • tractional retinal detachment
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • senile dyspnea
  • moist cough
  • allergic rhinitis
  • residual sputum
  • cough
  • epistaxis
  • allergic rhinitis
  • skin laceration
  • rib fracture
  • ligamentous injury syndrome
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • orthostatic vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass
  • anxiety

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should preferably be maintained at room temperature between 1 to 30 degrees Celsius. This helps to maintain the effectiveness of the medication for a longer period and ensures safe usage.

Appearance and packaging

Appearance

Yellow, egg-shaped sustained-release film-coated tablet

Package unit

Domestic use - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.